Tiancong He
Overview
Explore the profile of Tiancong He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, He M, He T, Ouyang X, Shen X, Shi W, et al.
Br J Cancer
. 2024 Jan;
130(6):987-1000.
PMID: 38253702
Background: HPV-independent cervical cancers (HPV-ind CCs) are uncommon with worse prognosis and poorly understood. This study investigated the molecular characteristics of HPV-ind CCs, aiming to explore new strategies for HPV-ind...
2.
Jiang W, Wu Y, He T, Zhu H, Ke G, Xiang L, et al.
Mol Cancer Ther
. 2019 Nov;
19(2):337-347.
PMID: 31666350
This study aims to explore whether E545K, the most common hotspot mutation of in cervical cancer, confers radioresistance to cervical cancer cells, to demonstrate the underling mechanism, and to develop...
3.
Jiang W, He T, Liu S, Zheng Y, Xiang L, Pei X, et al.
J Hematol Oncol
. 2018 Dec;
11(1):139.
PMID: 30547809
Background: The study aims to present the effect of PIK3CA E542K and E545K mutations on glucose metabolism and proliferation and identify their underlying mechanisms in cervical cancer. Methods: The maximum...
4.
Jiang W, Ye S, Xiang L, Yang W, He T, Pei X, et al.
J Ovarian Res
. 2018 Jul;
11(1):58.
PMID: 29986747
Background: Ovarian clear cell carcinoma is a distinct histologic subtype with grave survival. The underlying molecular mechanism is not fully elucidated. However, we don't have many cell lines, which are...
5.
Xiang L, Jiang W, Ye S, He T, Pei X, Li J, et al.
Gynecol Oncol
. 2017 Dec;
148(2):311-316.
PMID: 29279289
Objective: ERBB2 mutations have been found in a subset of invasive cervical cancer (ICC). Nevertheless, the prevalence, mutation spectrum, clinicopathological relevance, human papillomavirus (HPV)-genotype association and prognostic significance of ERBB2-mutated...
6.
Jiang W, Xiang L, Pei X, He T, Shen X, Wu X, et al.
J Gynecol Oncol
. 2017 Nov;
29(1):e4.
PMID: 29185262
Objective: The predictive and prognostic role of KRAS mutations in cervical cancer remains inconclusive. The aim of this study was to explore the clinicopathological and prognostic relevance of KRAS mutations...
7.
Pei X, Xiang L, Ye S, He T, Cheng Y, Yang W, et al.
Gynecol Oncol
. 2017 Sep;
147(3):589-596.
PMID: 28954697
Objective: This study sought to explore the outcomes and prognostic factors of patients with small cell neuroendocrine carcinoma of the cervix (SCNEC) and to determine the effects of adjuvant treatment...
8.
Ye S, He T, Liang S, Chen X, Wu X, Yang H, et al.
BMC Cancer
. 2017 May;
17(1):317.
PMID: 28476108
Background: To evaluate the procedures and complications of diaphragm peritonectomy (DP) and diaphragm full-thickness resection (DFTR) during primary cytoreduction for advanced stage epithelial ovarian cancer. Methods: All the patients with...
9.
Xiang L, Tu Y, He T, Shen X, Li Z, Wu X, et al.
J Gynecol Oncol
. 2016 Aug;
27(6):e62.
PMID: 27550408
Objective: Distal pancreatectomy with splenectomy may be required for optimal cytoreductive surgery in patients with epithelial ovarian cancer (EOC) metastasized to splenic hilum. This study evaluates the morbidity and treatment...